» Articles » PMID: 31835904

Economic Burden of Depression and Associated Resource Use in Manitoba, Canada

Overview
Specialty Psychiatry
Date 2019 Dec 15
PMID 31835904
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To characterize the health-care utilization and economic burden associated with depression in Manitoba, Canada.

Methods: Patient-level data were retrieved from the Manitoba Centre for Health Policy administrative, clinical, and laboratory databases for the study period of January 1, 1996, through December 31, 2016. Patients were assigned to the depression cohort based on diagnoses recorded in hospitalizations and outpatient physician claims, as well as antidepressant prescription drug claims. A comparison cohort of nondepressed subjects, matched with replacement for age, gender, place of residence (urban vs. rural), and index date, was created. Demographics, comorbidities, intentional self-harm, mortality, health-care utilization, prescription drug utilization, and costs of health-care utilization and social services were compared between depressed patients and matched nondepressed patients, and incidence rate ratios and hazard ratios were reported.

Results: There were 190,065 patients in the depression cohort and 378,177 patients in the nondepression cohort. Comorbidities were 43% more prevalent among depressed patients. Intentional self-harm, all-cause mortality, and suicide mortality were higher among patients with depression than the nondepression cohort. Health-care utilization-including hospitalizations, physician visits, physician-provided psychotherapy, and prescription drugs-was higher in the depression than the nondepression cohort. Mean health-care utilization costs were 3.5 times higher among depressed patients than nondepressed patients ($10,064 and $2,832, respectively). Similarly, mean social services costs were 3 times higher ($1,522 and $510, respectively). Overall, depression adds a total average cost of $8,244 ( = $40,542) per person per year.

Conclusions: Depression contributes significantly to health burden and per patient costs in Manitoba, Canada. Extrapolation of the results to the entire Canadian health-care system projects an excess of $12 billion annually in health system spending.

Citing Articles

Healthcare utilisation in people living with HIV: the role of substance use, mood/anxiety disorders and unsustained viral suppression - a retrospective cohort study in British Columbia, Canada, 2001-2019.

Shayegi-Nik S, Wang L, Magee C, Li J, Budu M, Kooij K BMJ Open. 2025; 15(3):e088818.

PMID: 40044190 PMC: 11883530. DOI: 10.1136/bmjopen-2024-088818.


Relationship between pharmacotherapy for major depressive disorder and healthcare utilisation in British Columbia, Canada: a retrospective population-based cohort.

Vijh R, Waheed Z, Peterson S, Bunka M, Pang N, Edwards L BMJ Open. 2025; 14(12):e078287.

PMID: 39806661 PMC: 11667282. DOI: 10.1136/bmjopen-2023-078287.


Ultrastructural features of psychological stress resilience in the brain: a microglial perspective.

Gonzalez Ibanez F, VanderZwaag J, Deslauriers J, Tremblay M Open Biol. 2024; 14(11):240079.

PMID: 39561812 PMC: 11576122. DOI: 10.1098/rsob.240079.


Comparing Email Versus Text Messaging as Delivery Platforms for Supporting Patients With Major Depressive Disorder: Noninferiority Randomized Controlled Trial.

Adu M, Eboreime O, Shalaby R, Eboreime E, Agyapong B, Dias R JMIR Form Res. 2024; 8():e59003.

PMID: 39250182 PMC: 11420606. DOI: 10.2196/59003.


The relationship between depression and lipid accumulation product: a population-based study.

Zhu X, Wang P, Yue Y, Wu T, Cui J, Shu Y Front Psychiatry. 2024; 15:1395766.

PMID: 39041045 PMC: 11260732. DOI: 10.3389/fpsyt.2024.1395766.


References
1.
Brownell M, Yogendran M . Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates. Can J Psychiatry. 2001; 46(3):264-72. DOI: 10.1177/070674370104600307. View

2.
Freedman A, Wideroff L, Olson L, Davis W, Klabunde C, Srinath K . US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet A. 2003; 120A(1):63-71. DOI: 10.1002/ajmg.a.10192. View

3.
Lim K, Jacobs P, Ohinmaa A, Schopflocher D, Dewa C . A new population-based measure of the economic burden of mental illness in Canada. Chronic Dis Can. 2008; 28(3):92-8. View

4.
Ohayon M, Schatzberg A . Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry. 2002; 159(11):1855-61. DOI: 10.1176/appi.ajp.159.11.1855. View

5.
Harris E, Barraclough B . Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997; 170:205-28. DOI: 10.1192/bjp.170.3.205. View